Vanguard Group’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,444	Closed	-$32.1K	–	4496
2023 Q4	$32.1K	Hold	3,444	–	–	﹤0.01%	4409
2023 Q3	$54.5K	Sell	3,444 -46	-1%	-$2.34K	﹤0.01%	4402
2023 Q2	$261K	Hold	3,490	–	–	﹤0.01%	4261
2023 Q1	$293K	Hold	3,490	–	–	﹤0.01%	4258
2022 Q4	$472K	Buy	3,490 +3	+0.1%	+$372	﹤0.01%	4113
2022 Q3	$363K	Buy	3,487 +24	+0.7%	+$4.71K	﹤0.01%	4301
2022 Q2	$785K	Hold	3,463	–	–	﹤0.01%	4163
2022 Q1	$960K	Buy	3,463 +495	+17%	+$137K	﹤0.01%	4220
2021 Q4	$648K	Hold	2,968	–	–	﹤0.01%	4375
2021 Q3	$1.35M	Buy	2,968 +108	+4%	+$53.9K	﹤0.01%	4174
2021 Q2	$1.68M	Buy	2,860 +1,697	+146%	+$897K	﹤0.01%	4015
2021 Q1	$728K	Buy	1,163 +288	+33%	+$185K	﹤0.01%	4069
2020 Q4	$380K	Buy	875 +197	+29%	+$82.4K	﹤0.01%	4005
2020 Q3	$253K	Buy	678 +19	+3%	+$20.7K	﹤0.01%	3929
2020 Q2	$499K	Hold	659	–	–	﹤0.01%	3766
2020 Q1	$553K	Buy	659 +53	+9%	+$60.1K	﹤0.01%	3652
2019 Q4	$617K	Buy	606 +1	+0.2%	+$1.13K	﹤0.01%	3756
2019 Q3	$912K	Buy	605 +353	+140%	+$397K	﹤0.01%	3675
2019 Q2	$293K	Buy	252 +2	+0.8%	+$2.67K	﹤0.01%	3910
2019 Q1	$276K	Buy	250 +3	+1%	+$2.88K	﹤0.01%	3867
2018 Q4	$195K	Buy	247 +12	+5%	+$14.7K	﹤0.01%	3908
2018 Q3	$341K	Buy	+235	New	+$485K	﹤0.01%	3916